A Phase II Study of Modified FOLFOX6 for Advanced Gastric Cancer Refractory to Standard Therapies.
Mitani S, Kadowaki S, Komori A, Kondoh C, Oze I, Kato K, Masuishi T, Honda K, Narita Y, Taniguchi H, Ando M, Tanaka T, Tajika M, Muro K.
Mitani S, et al. Among authors: kondoh c.
Adv Ther. 2020 Jun;37(6):2853-2864. doi: 10.1007/s12325-020-01358-2. Epub 2020 May 7.
Adv Ther. 2020.
PMID: 32378071
Clinical Trial.